Figure 2. Vasorelaxing activity of dipeptides in SHR mesenteric arteries in the early (A) or advanced stage (B and C). Dipeptides from dipeptide mixtures with the most potent vasorelaxing activity were used at a dose of 1 μM. Values are means (n = 2-4).